Galapagos NV
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
16 dec 2013 - 07:39
Statutaire naam
Galapagos NV
Titel
Galapagos selects pre-clinical candidate for cystic fibrosis
Bericht
• Novel potentiator shows more activity in pre-clinical studies than market leader Kalydeco®
• Start of Phase 1 expected before end 2014
Mechelen, Belgium; 16 December 2013 - Galapagos NV (Euronext: GLPG) announced today that it nominated a pre-clinical candidate potentiator for clinical development in its cystic fibrosis (CF) program.
Datum laatste update: 27 februari 2026